Dr. Kevin Clancy Discusses New Anti-Coagulants’ Effect on Stroke in those with AFib

11/03/2014

Kevin Clancy, MD, FACC, a Barnabas Health Medical Group (BHMG) physician with Cardiology Consultants of Toms River, recently authored a BHMG blog post on a new group of medications used to prevent stroke in people with atrial fibrillation (AFib).

Those with AFib – the most common type of irregular heart rhythm (arrhythmia) – are at an increased risk for stroke from cardiac embolisms (blood clots). AFib is often treated with blood thinners like warfarin, an anti-coagulant that helps prevent blood clots that can lead to stroke. In his blog post, Dr. Clancy discusses the difference between traditional blood-thinning agents and the new group of anti-coagulants in preventing stroke among those with AFib. Click here to read Dr. Clancy’s post.

The BHMG Healthy Living Blog was designed to offer patients and the public with information on the latest health care services, trending medical issues and news.